213 related articles for article (PubMed ID: 9306059)
1. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids.
Arican M; Coughlan AR; Clegg PD; Carter SD
J Vet Med A Physiol Pathol Clin Med; 2000 Oct; 47(8):449-56. PubMed ID: 11075535
[TBL] [Abstract][Full Text] [Related]
3. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
4. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources.
Clegg PD; Coughlan AR; Carter SD
Equine Vet J; 1998 Sep; 30(5):416-23. PubMed ID: 9758100
[TBL] [Abstract][Full Text] [Related]
5. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids.
Misumi K; Vilim V; Clegg PD; Thompson CC; Carter SD
Osteoarthritis Cartilage; 2001 Feb; 9(2):119-27. PubMed ID: 11237659
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
Clegg PD; Carter SD
Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM
Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746
[TBL] [Abstract][Full Text] [Related]
8. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD
Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis.
Coughlan AR; Robertson DH; Bennett D; May C; Beynon RJ; Carter SD
Vet Rec; 1998 Aug; 143(8):219-23. PubMed ID: 9770764
[TBL] [Abstract][Full Text] [Related]
10. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
12. The effect of drugs commonly used in the treatment of equine articular disorders on the activity of equine matrix metalloproteinase-2 and 9.
Clegg PD; Jones MD; Carter SD
J Vet Pharmacol Ther; 1998 Oct; 21(5):406-13. PubMed ID: 9811443
[TBL] [Abstract][Full Text] [Related]
13. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.
Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL
Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615
[TBL] [Abstract][Full Text] [Related]
14. Cartilage-derived retinoic acid-sensitive protein in equine synovial fluid from healthy and diseased joints.
Berg LC; Lenz J; Kjelgaard-Hansen M; Thomsen PD; Jacobsen S
Equine Vet J; 2008 Sep; 40(6):553-7. PubMed ID: 18267886
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
16. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis.
Brama PA; van den Boom R; DeGroott J; Kiers GH; van Weeren PR
Equine Vet J; 2004 Jan; 36(1):34-40. PubMed ID: 14756369
[TBL] [Abstract][Full Text] [Related]
17. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection.
Makowski GS; Ramsby ML
Clin Chim Acta; 2003 Mar; 329(1-2):77-81. PubMed ID: 12589968
[TBL] [Abstract][Full Text] [Related]
18. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
Skiöldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S
Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic enzymes in equine joints with infectious arthritis.
Spiers S; May SA; Harrison LJ; Bennett D; Edwards GB
Equine Vet J; 1994 Jan; 26(1):48-50. PubMed ID: 8143664
[TBL] [Abstract][Full Text] [Related]
20. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease.
Kubota E; Kubota T; Matsumoto J; Shibata T; Murakami KI
J Oral Maxillofac Surg; 1998 Feb; 56(2):192-8. PubMed ID: 9461144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
